课题基金 / 基金详情

THE ROLE OF ALPHA-DEFENSINS IN CYSTIC FIBROSIS LUNG DISE

THE ROLE OF ALPHA-DEFENSINS IN CYSTIC FIBROSIS LUNG DISE
α-防御素在囊性纤维化肺疾病中的作用
批准号:
6490289
负责人:
L T SPENCER
金额:
$12.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-05 至 2004-12-31

项目摘要

项目成果

L T SPENCER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As the principal investigator of this K23 proposal, I will complete fellowship training in pediatric pulmonology at the University of Florida in June 1999. I have accepted a faculty position in the same division effective in July 1999. Having completed 3 years of full-time research in basic and applied sciences in addition to residency and accelerated clinical and research fellowship training, my immediate career goals are to pursue further training in methodology designed to translate investigative findings of biomedical research to clinically useful applications. The proposed training program consists of an early period of relevant didactic training and initiation of research efforts, and culminates in 3 years of mentored research at 80 percent effort. The skills and experience obtained during this 5 year training program will provide opportunities for further research and funding in an independent manner. The proposed research is designed to characterize the role of neutrophil or alpha-defensins in cystic fibrosis (CF) lung disease. Our preliminary data indicates that alpha-defensin levels are significantly elevated in the airways of CF patients compared to healthy volunteers. These peptides possess cytotoxic and inflammatory properties, and may play a role in chronic endobronchial infection in CF. Using bronchoscopic evaluation of the lungs and bronchoalveolar lavage, we plan to define the specific and net effect of alpha-defensins in CF lung disease. We also plan to explore the possibility of modulation of deleterious effects of alpha-defensin with aerosolized alpha1- antitypsin, a molecule that may possess a wide range of therapeutic properties in CF lung disease. The methodology of this project is diverse, consisting of patient selection and recruitment, research bronchoscopy and specimen processing, complimentary ex vivo assays and experiments, collection of clinical data, clinical trial design and administration, and a broad range of statistical analysis methods. Structured didactic training will complement this project in providing multidisciplinary training geared towards independence in the conductance of patient-oriented research. Following completion of this training and research, my long-term career interest will remain in the area of pathogenesis and applied clinical intervention of neutrophil-mediated pulmonary disease in pediatric patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: A MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED S
  • 批准号:
    7717090
  • 项目类别:
  • 资助金额:
    $0.05万
  • 财政年份:
    2007
  • 负责人:
    L T SPENCER
  • 依托单位:
AZTREONAM LYSINATE FOR INHALATION IN CYSTIC FIBROSIS PATIENTS WITH PULMONARY P1
  • 批准号:
    7605483
  • 项目类别:
  • 资助金额:
    $0.21万
  • 财政年份:
    2006
  • 负责人:
    L T SPENCER
  • 依托单位:
AIR-CF2 TRIAL WITH AZTREONAM LYSINATE FOR INHALATION IN CF PAT WITH P ARUGINOSA
  • 批准号:
    7605478
  • 项目类别:
  • 资助金额:
    $1.98万
  • 财政年份:
    2006
  • 负责人:
    L T SPENCER
  • 依托单位:
A MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY OF DIABETE
  • 批准号:
    7605469
  • 项目类别:
  • 资助金额:
    $0.21万
  • 财政年份:
    2006
  • 负责人:
    L T SPENCER
  • 依托单位:
海外基金